Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [41] Continuous renal replacement therapy is associated with acute cardiac stunning in critically ill patients
    Slessarev, Marat
    Salerno, Fabio
    Ball, Ian M.
    McIntyre, Christopher W.
    HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 325 - 332
  • [42] Ultrafiltration in Japanese critically ill patients with acute kidney injury on renal replacement therapy
    Kitamura, Koichi
    Hayashi, Koichi
    Fujitani, Shigeki
    Murugan, Raghavan
    Suzuki, Toshihiko
    JOURNAL OF INTENSIVE CARE, 2021, 9 (01)
  • [43] Renal replacement in critically ill patients: the age factor
    F Occhigrossi
    V Angeloni
    R Rocca
    A Filippini
    P Assisi
    M Podestà
    Critical Care, 8 (Suppl 1):
  • [44] Intermittent hemodiafiltration in acute renal failure in critically ill patients
    Pettilä, V
    Tiula, E
    CLINICAL NEPHROLOGY, 2001, 56 (04) : 324 - 331
  • [45] The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy
    Lin, Yu-Feng
    Ko, Wen-Je
    Chu, Tzong-Shinn
    Chen, Yih-Sharng
    Wu, Vin-Cent
    Chen, Yung-Ming
    Wu, Ming-Shiou
    Chen, Yung-Wei
    Tsai, Ching-Wei
    Shiao, Chih-Chung
    Li, Wen-Yi
    Hu, Fu-Chang
    Tsai, Pi-Ru
    Tsai, Tun-Jun
    Wu, Kwan-Dun
    AMERICAN JOURNAL OF SURGERY, 2009, 198 (03) : 325 - 332
  • [46] Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis
    Bagshaw, Sean M.
    Berthiaume, Luc R.
    Delaney, Anthony
    Bellomo, Rinaldo
    CRITICAL CARE MEDICINE, 2008, 36 (02) : 610 - 617
  • [47] Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury
    Helmut Schiffl
    Susanne M. Lang
    International Urology and Nephrology, 2013, 45 : 191 - 197
  • [48] Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury
    Schiffl, Helmut
    Lang, Susanne M.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (01) : 191 - 197
  • [49] Optimal timing of renal replacement therapy for favourable outcome in patients of acute renal failure following cardiac surgery
    Shanshank Tripathi
    Shantanu Pande
    Pulkit Malhotra
    Supaksh Mahindru
    Ankit Thukral
    Ankush Singh Kotwal
    Gauranga Majumdar
    Surendra Kumar Agarwal
    Amit Gupta
    Indian Journal of Thoracic and Cardiovascular Surgery, 2020, 36 : 127 - 133
  • [50] Impact of the intensity of intermittent renal replacement therapy in critically ill patients
    Alicia Molina-Andújar
    Pau Alcubilla
    Pedro Santiago
    Miquel Blasco
    David Cucchiari
    Gaston Piñeiro
    Rut Andrea
    Sara Fernández
    Enric Reverter
    Jordi Mercadal
    Eduard Quintana
    Esteban Poch
    Journal of Nephrology, 2021, 34 : 105 - 112